NCT03009526View on ClinicalTrials.gov

Efficacy and Safety of IPTp-DP Versus IPTp-SP in Malawi

PHASE3CompletedINTERVENTIONAL
Enrollment

602

Participants

Timeline

Start Date

January 17, 2017

Primary Completion Date

October 24, 2018

Study Completion Date

October 24, 2018

Conditions
MalariaPregnancy
Interventions
DRUG

Sulfadoxine-pyrimethamine

500 mg sulfadoxine and 25 mg pyrimethamine

DRUG

dihydroartemisinin-piperaquine

40 mg dihydroartemisinin and 320 mg piperaquine

Trial Locations (1)

Unknown

Malaria Alert Center, University of Malawi College of Medicine, Liwonde

All Listed Sponsors
collaborator

Centers for Disease Control and Prevention

FED

lead

Kamuzu University of Health Sciences

OTHER

NCT03009526 - Efficacy and Safety of IPTp-DP Versus IPTp-SP in Malawi | Biotech Hunter | Biotech Hunter